MedPath

Type of injectable fluids and associated electrolyte abnormalities among childre

Phase 4
Conditions
Health Condition 1: null- Children not critically ill admitted for various diseases and expected to receive fluids for 24 hours.
Registration Number
CTRI/2018/05/014231
Lead Sponsor
SRM Medical college Hospital research institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Children who are judged by the treating physician to require i.v. maintenance fluid administration for at least the following 24 h of their hospital stay will be eligible for inclusion in the study.

Exclusion Criteria

Children with hyponatraemia (plasma sodium <130 mEq/L), hypernatraemia (plasma sodium >150 mEq/L) or hyperglycaemia (blood glucose >180 mg/dL), dehydration, shock, severe malnutrition, cirrhosis of liver, congestive heart failure, acute or chronic renal failure and nephrotic syndrome will be excluded. Children who were receiving drugs that alter plasma sodium levels, such as frusemide, hydrochlorothiazide, vasopressin or desmopressin and mannitol, will also be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath